Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses.
Hoft DF, Brown RM, Belshe RB. Hoft DF, et al. Clin Infect Dis. 2000 Jun;30 Suppl 3:S217-22. doi: 10.1086/313864. Clin Infect Dis. 2000. PMID: 10875787 Clinical Trial.
Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guérin.
Kemp EB, Belshe RB, Hoft DF. Kemp EB, et al. Among authors: hoft df. J Infect Dis. 1996 Jul;174(1):113-9. doi: 10.1093/infdis/174.1.113. J Infect Dis. 1996. PMID: 8655980 Clinical Trial.
Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses.
Hoft DF, Farrar PL, Kratz-Owens K, Shaffer D. Hoft DF, et al. Infect Immun. 1996 Sep;64(9):3800-10. doi: 10.1128/IAI.64.9.3800-3810.1996. Infect Immun. 1996. PMID: 8751932 Free PMC article.
Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
Hoft DF, Brown RM, Roodman ST. Hoft DF, et al. J Immunol. 1998 Jul 15;161(2):1045-54. J Immunol. 1998. PMID: 9670986 Clinical Trial.
Persistence and boosting of bacille Calmette-Guérin-induced delayed-type hypersensitivity.
Hoft DF, Tennant JM. Hoft DF, et al. Ann Intern Med. 1999 Jul 6;131(1):32-6. doi: 10.7326/0003-4819-131-1-199907060-00007. Ann Intern Med. 1999. PMID: 10391813 Clinical Trial.
A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination.
Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyono H, McGhee JR, Belisle JT, Milligan TW, Miller JP, Belshe RB. Hoft DF, et al. J Lab Clin Med. 1999 Sep;134(3):244-52. doi: 10.1016/s0022-2143(99)90204-4. J Lab Clin Med. 1999. PMID: 10482309 Clinical Trial.
Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.
Hoft DF, Schnapp AR, Eickhoff CS, Roodman ST. Hoft DF, et al. Infect Immun. 2000 Jan;68(1):197-204. doi: 10.1128/iai.68.1.197-204.2000. Infect Immun. 2000. PMID: 10603388 Free PMC article.
Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination.
Hoft DF, Leonardi C, Milligan T, Nahass GT, Kemp B, Cook S, Tennant J, Carey M. Hoft DF, et al. Clin Infect Dis. 1999 Apr;28(4):785-90. doi: 10.1086/515201. Clin Infect Dis. 1999. PMID: 10825039 Clinical Trial.
In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin.
Worku S, Hoft DF. Worku S, et al. Among authors: hoft df. Clin Infect Dis. 2000 Jun;30 Suppl 3:S257-61. doi: 10.1086/313887. Clin Infect Dis. 2000. PMID: 10875795
Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus.
Ray R, Hoft DF, Meyer K, Brown R, Lagging LM, Belshe RB. Ray R, et al. Among authors: hoft df. Virus Res. 2001 Jun;75(2):147-54. doi: 10.1016/s0168-1702(01)00237-4. Virus Res. 2001. PMID: 11325469
118 results
Jump to page
Feedback